The drug is conditionally recommended, said the WHO Guideline Development Group of international experts in The British Medical Journal (BMJ).

Reuters

United Kingdom

WHO recommends Merck's new oral corona drug for high-risk patients

The WHO has however warned against using the drug on young and healthy patients, including children, and pregnant and breastfeeding women.

Media Bias/Fact Check

News18 India

Mukesh Ambani

India

WHO Recommends Covid Pill Molnupiravir for High-risk Patients as Controlled Trials Bring Hope

[Reuters] --On the 2nd, the World Health Organization (WHO) expert committee recommended the use of the new coronavirus infectious disease oral drug "Mornupiravir" by the major US pharmaceutical company Merck for high-risk patients. Conditionally recommended for use in non-severe patients at high risk of hospitalization. People with immune disorders, unvaccinated people, the elderly, people with chronic diseases, etc. are targeted. The expert co…

Ad Fontes Media

All Sides

The Woodbridge Company

The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.

NDTV

Independent Media

Gautam Adani

New Delhi

Delhi

WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients

Hindustan Times

HT Media

Molnupiravir can be used for high-risk Covid patients: WHO

Sol Amaya (CNN) — La Organización Mundial de la Salud emitió una recomendación para el medicamento antiviral molnupiravir para personas con infecciones no graves por covid-19 que tienen un alto riesgo de hospitalización. Según una guía actualizada de la OMS sobre medicamentos para el covid-19 publicada este miércoles en el BMJ, la organización define el

KIFI

News-Press & Gazette Company

Idaho Falls

Bonneville County

Idaho

United States

La OMS recomienda molnupiravir antiviral para personas con covid-19 no grave con alto riesgo de hospitalización - Local News 8

Sol Amaya(CNN) — The World Health Organization has issued a recommendation for the antiviral drug molnupiravir for people with non-severe COVID-19 infections who are at high risk of hospitalization. According to updated WHO guidance on COVID-19 medications -19 published this Wednesday in the BMJ, the organization defines non-severe covid-19 as the absence of criteria for a serious or critical infection, such as signs of pneumonia or a low level …

KRDO

Colorado Springs

El Paso County

Colorado

WHO recommends antiviral molnupiravir for people with non-severe covid-19 at high risk of hospitalization

KVIA

Panama City

Bay County

Florida

Author: Thu, 2022-03-03 03:41
	PARIS: The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalization, such as older people or the unvaccinated.
	The pill, called molnupiravir and developed by US pharmaceutical Merck, is taken as soon as possible after Covid-19 symptoms develop and then for the following five days.
	A WHO group of experts said in the B…

Arab News

Saudi Research and Marketing Group

Riyadh

Riyadh Province

Saudi Arabia

WHO recommends Merck Covid pill for non-severe, at-risk patients

The World Health Organization on Wednesday recommended an anti-COVID pill be taken by sufferers who have mild symptoms but are at high risk of hospitalization, such as older people or the unvaccinated.

Medical Xpress

WHO recommends Merck COVID pill for non-severe, at-risk patients

(Reuters) – A World Health Organization (WHO) panel on Wednesday backed the use of Merck & Co Inc’s COVID-19 antiviral pill for high-risk patients.The expert panel conditionally recommended the pill, molnupiravir, for patients with non-severe disease who are at high risk of hospitalisation, such as the immunocompromised, the unvaccinated, older people and those with chronic diseases.The recommendation was based on new data from six clinical tria…

FijiTimes

Motibhai Group of Companies

Fiji

WHO recommends Merck’s COVID pill for high-risk patients

Europe

World Health Organization

Coronavirus

Medical

Geneva, Switzerland

New York City

Geneva

Switzerland

News Medical

Geeky News

AsiaOne News, AsiaOne Latest News, AsiaOne Magazine India |

The WHO backed the use of Merck & Co Inc's Covid-19 pill for high-risk patients. Post-six clinical trials involving 4,796 patients, the recommendation was made based on new data. Molnupiravir pill was conditionally recommended by the expert panel for patients with non-severe diseases.

Molnupiravir can be used for high-risk Covid patients: WHO

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics